Esmail, Sagira A.
HRN: 09-97-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
CEFTRIAXONE 1G (VIAL)
08/12/2025
08/18/2025
IV
2 Grams
IV OD
Uti
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: